Platelet-derived growth factor in glioblastoma—driver or biomarker?

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N Engl J Med. 1980;303:878–80.
   PubMed Web of Science ®Google Scholar
• Temin HM. Studies on carcinogenesis by avian sarcoma viruses. 3. The differential effect of serum and polyanions on multiplication of uninfected and converted cells. J Natl Cancer Inst. 1966;37:167–75.
   PubMed Web of Science ®Google Scholar
• Temin HM. Control of multiplication of uninfected rat cells and rat cells converted by murine sarcoma virus. J Cell Physiol. 1970;75:107–19.
   Google Scholar
• Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983;221:275–7.
   PubMed Web of Science ®Google Scholar
• Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–9.
   PubMed Web of Science ®Google Scholar
• Johnsson A, Betsholtz C, Heldin CH, Westermark B. Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus. Nature. 1985;317:438–40.
   PubMed Web of Science ®Google Scholar
• Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer. 1967;2:434–47.
   PubMed Web of Science ®Google Scholar
• Westermark B, Wasteson A. The response of cultured human normal glial cells to growth factors. Adv Metab Disord. 1975;8:85–100.
   PubMedGoogle Scholar
• Heldin CH, Westermark B, Wasteson A. Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. J Cell Physiol. 1980;105:235–46.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature. 1986;319:511–14.
   PubMed Web of Science ®Google Scholar
• Nister M, Heldin CH, Wasteson A, Westermark B. A platelet-derived growth factor analog produced by a human clonal glioma cell line. Ann N Y Acad Sci. 1982;397:25–33.
   PubMed Web of Science ®Google Scholar
• Nister M, Heldin CH, Wasteson A, Westermark B. A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. Proc Natl Acad Sci USA. 1984;81:926–30.
   PubMed Web of Science ®Google Scholar
• Hammacher A, Nister M, Westermark B, Heldin CH. A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet-derived growth factor. Eur J Biochem. 1988;176:179–86.
   PubMedGoogle Scholar
• Nazarenko I, Hede SM, He X, Hedren A, Thompson J, Lindstrom MS, et al. PDGF and PDGF receptors in glioma. Ups J Med Sci. 2012;117:99–112.
   PubMed Web of Science ®Google Scholar
• Westermark B. Glioblastoma–a moving target. Ups J Med Sci. 2012;117:251–6.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–312.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–316.
   PubMed Web of Science ®Google Scholar
• Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982;69:1046–9.
   PubMed Web of Science ®Google Scholar
• Grotendorst GR, Chang T, Seppa HE, Kleinman HK, Martin GR. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol. 1982;113:261–6.
   PubMedGoogle Scholar
• Westermark B, Siegbahn A, Heldin CH, Claesson-Welsh L. B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc Natl Acad Sci USA. 1990;87:128–32.
   PubMed Web of Science ®Google Scholar
• Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988;53:309–19.
   PubMed Web of Science ®Google Scholar
• Pringle N, Collarini EJ, Mosley MJ, Heldin CH, Westermark B, Richardson WD. PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. EMBO J. 1989;8:1049–56.
   PubMed Web of Science ®Google Scholar
• Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron. 1998;20:869–82.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Calver AR, Kruger WH, Mudhar HS, Michalovich D, Takakura N, et al. PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron. 1996;17:1117–31.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development. 1999;126:457–67.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Calver AR, Richardson WD. Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol. 2000;10:1283–6.
   PubMed Web of Science ®Google Scholar
• Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci. 2004;25:252–62.
   PubMed Web of Science ®Google Scholar
• Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, et al. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 2006;51:187–99.
   PubMed Web of Science ®Google Scholar
• Deinhardt F. Biology of primate retroviruses. In Klein G, editor. Viral oncology. New York: Raven Press; 1980. p 357–98.
   Google Scholar
• Wolfe LG, Deinhardt F, Theilen GH, Rabin H, Kawakami T, Bustad LK. Induction of tumors in marmoset monkeys by simian sarcoma virus, type 1 (Lagothrix): a preliminary report. J Natl Cancer Inst. 1971;47:1115–20.
   PubMed Web of Science ®Google Scholar
• Nister M, Westermark B. Mechanisms of altered growth control. Growth factors. In Bigner DD, McLendon RE, Bruner JM, editors. Russel and Rubinstein’s Pathology of tumors of the nervous system. 6th ed. London: Arnold; 1998. p 83–116.
   Google Scholar
• Uhrbom L, Hesselager G, Nister M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998;58:5275–9.
   PubMed Web of Science ®Google Scholar
• Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001;15:1913–25.
   PubMed Web of Science ®Google Scholar
• Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009;28:2266–75.
   PubMed Web of Science ®Google Scholar
• Lindberg N, Jiang Y, Xie J, Bolouri H, Kastemar M, Olofsson T, et al. Oncogenic 1 signaling is dominant to cell of origin and dictates astrocytic or2 oligodendroglial tumor development from oligodendrocyte precursor cells. J Cell Sci. 2014; In press.
   Google Scholar
• Jiang Y, Uhrbom L. On the origin of glioma. Ups J Med Sci. 2012;117:113–21.
   PubMed Web of Science ®Google Scholar
• Hede SM, Hansson I, Afink GB, Eriksson A, Nazarenko I, Andrae J, et al. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Glia. 2009;57:1143–53.
   PubMed Web of Science ®Google Scholar
• Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res. 2004;64:4783–9.
   PubMed Web of Science ®Google Scholar
• Devare SG, Reddy EP, Robbins KC, Andersen PR, Tronick SR, Aaronson SA. Nucleotide sequence of the transforming gene of simian sarcoma virus. Proc Natl Acad Sci USA. 1982;79:3179–82.
   Google Scholar
• Westermark B, Johnsson A, Betsholtz C, Heldin CH. Biological properties of simian sarcoma virus and its oncogene product. In Hofschneider PH, Munk K, editors. Viruses in human tumors. Contributions to oncology. Vol. 24 Karger, Basel, München, Paris, London, New York, New Delhi, Singapore, Tokyo, Sydney; 1987. p 51–61.
   Google Scholar
• Lindberg N, Holland EC. PDGF in gliomas: more than just a growth factor? Ups J Med Sci. 2012;117:92–8.
   PubMed Web of Science ®Google Scholar
• Johansson FK, Brodd J, Eklof C, Ferletta M, Hesselager G, Tiger CF, et al. Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci USA. 2004;101:11334–7.
   PubMed Web of Science ®Google Scholar
• Johansson Swartling F. Identifying candidate genes involved in brain tumor formation. Ups J Med Sci. 2008;113:1–38.
   PubMed Web of Science ®Google Scholar
• Tchougounova E, Jiang Y, Brasater D, Lindberg N, Kastemar M, Asplund A, et al. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene. 2009;28:1537–48.
   PubMed Web of Science ®Google Scholar
• Heng YH, McLeay RC, Harvey TJ, Smith AG, Barry G, Cato K, et al. NFIX regulates neural progenitor cell differentiation during hippocampal morphogenesis. Cereb Cortex. 2014;24:261–79.
   Google Scholar
• Martynoga B, Mateo JL, Zhou B, Andersen J, Achimastou A, Urban N, et al. Epigenomic enhancer annotation reveals a key role for NFIX in neural stem cell quiescence. Genes Dev. 2013;27:1769–86.
   Google Scholar
• Dave UP, Jenkins NA, Copeland NG. Gene therapy insertional mutagenesis insights. Science. 2004;303:333.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–19.
   PubMed Web of Science ®Google Scholar
• Assanah MC, Bruce JN, Suzuki SO, Chen A, Goldman JE, Canoll P. PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia. 2009;57:1835–47.
   PubMed Web of Science ®Google Scholar
• van Heyningen P, Calver AR, Richardson WD. Control of progenitor cell number by mitogen supply and demand. Curr Biol. 2001;11:232–41.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52:3213–19.
   PubMed Web of Science ®Google Scholar
• Di Rocco F, Carroll RS, Zhang J, Black PM. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery. 1998;42:341–6.
   PubMed Web of Science ®Google Scholar
• Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 1992;52:4550–3.
   PubMed Web of Science ®Google Scholar
• Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T. Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma. Tohoku J Exp Med. 1992;168:265–9.
   PubMed Web of Science ®Google Scholar
• Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T. Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene. 1992;7:627–33.
   PubMed Web of Science ®Google Scholar
• Martinho O, Longatto-Filho A, Lambros MB, Martins A, Pinheiro C, Silva A, et al. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer. 2009;101:973–82.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, et al. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 2010;24:2205–18.
   PubMed Web of Science ®Google Scholar
• Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, et al. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci USA. 2005;102:14344–9.
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Riester M, Cheng YK, Huse JT, Squatrito M, Helmy K, et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell. 2014;26:288–300.
   PubMed Web of Science ®Google Scholar
• Evans AS. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med. 1976;49:175–95.
   PubMed Web of Science ®Google Scholar
• Hagerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, et al. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol. 2011;13:1178–91.
   PubMed Web of Science ®Google Scholar
• Vassbotn FS, Ostman A, Langeland N, Holmsen H, Westermark B, Heldin CH, et al. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J Cell Physiol. 1994;158:381–9.
   PubMed Web of Science ®Google Scholar
• Dresemann G, Weller M, Rosenthal MA, Wedding U, Wagner W, Engel E, et al. Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol. 2010;96:393–402.
   PubMed Web of Science ®Google Scholar
• Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, et al. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer. 2009;101:1995–2004.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Nerio E, Holland EC. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med. 2004;10:1257–60.
   PubMed Web of Science ®Google Scholar
• Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell. 2003;3:439–43.
   PubMed Web of Science ®Google Scholar
• Heldin CH. Autocrine PDGF stimulation in malignancies. Ups J Med Sci. 2012;117:83–91.
   PubMed Web of Science ®Google Scholar
• Jonkers J, Berns A. Oncogene addiction: sometimes a temporary slavery. Cancer Cell. 2004;6:535–8.
   PubMed Web of Science ®Google Scholar
• McCormick F. Cancer therapy based on oncogene addiction. J Surg Oncol. 2011;103:464–7.
   PubMedGoogle Scholar
• Kitambi SS, Toledo EM, Usoskin D, Wee S, Harisankar A, Svensson R, et al. Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell. 2014;157:313–28.
   Google Scholar